163 related articles for article (PubMed ID: 11082705)
1. Lactacystin, a proteasome inhibitor: discovery and its application in cell biology.
Tomoda H; Omura S
Yakugaku Zasshi; 2000 Oct; 120(10):935-49. PubMed ID: 11082705
[TBL] [Abstract][Full Text] [Related]
2. Mechanistic studies on the inactivation of the proteasome by lactacystin: a central role for clasto-lactacystin beta-lactone.
Dick LR; Cruikshank AA; Grenier L; Melandri FD; Nunes SL; Stein RL
J Biol Chem; 1996 Mar; 271(13):7273-6. PubMed ID: 8631740
[TBL] [Abstract][Full Text] [Related]
3. Lactacystin and clasto-lactacystin beta-lactone modify multiple proteasome beta-subunits and inhibit intracellular protein degradation and major histocompatibility complex class I antigen presentation.
Craiu A; Gaczynska M; Akopian T; Gramm CF; Fenteany G; Goldberg AL; Rock KL
J Biol Chem; 1997 May; 272(20):13437-45. PubMed ID: 9148969
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin.
Fenteany G; Standaert RF; Lane WS; Choi S; Corey EJ; Schreiber SL
Science; 1995 May; 268(5211):726-31. PubMed ID: 7732382
[TBL] [Abstract][Full Text] [Related]
5. The proteasome participates in degradation of mutant alpha 1-antitrypsin Z in the endoplasmic reticulum of hepatoma-derived hepatocytes.
Teckman JH; Burrows J; Hidvegi T; Schmidt B; Hale PD; Perlmutter DH
J Biol Chem; 2001 Nov; 276(48):44865-72. PubMed ID: 11577074
[TBL] [Abstract][Full Text] [Related]
6. Mechanistic studies on the inactivation of the proteasome by lactacystin in cultured cells.
Dick LR; Cruikshank AA; Destree AT; Grenier L; McCormack TA; Melandri FD; Nunes SL; Palombella VJ; Parent LA; Plamondon L; Stein RL
J Biol Chem; 1997 Jan; 272(1):182-8. PubMed ID: 8995245
[TBL] [Abstract][Full Text] [Related]
7. Lactacystin, a specific inhibitor of the proteasome, induces apoptosis and activates caspase-3 in cultured cerebellar granule cells.
Pasquini LA; Besio Moreno M; Adamo AM; Pasquini JM; Soto EF
J Neurosci Res; 2000 Mar; 59(5):601-11. PubMed ID: 10686588
[TBL] [Abstract][Full Text] [Related]
8. The effect of the proteasome inhibitor lactacystin on the presentation of transporter associated with antigen processing (TAP)-dependent and TAP-independent peptide epitopes by class I molecules.
Bai A; Forman J
J Immunol; 1997 Sep; 159(5):2139-46. PubMed ID: 9278300
[TBL] [Abstract][Full Text] [Related]
9. Specific inhibition of the chymotrypsin-like activity of the proteasome induces a bipolar morphology in neuroblastoma cells.
Fenteany G; Schreiber SL
Chem Biol; 1996 Nov; 3(11):905-12. PubMed ID: 8939705
[TBL] [Abstract][Full Text] [Related]
10. The selective proteasome inhibitors lactacystin and epoxomicin can be used to either up- or down-regulate antigen presentation at nontoxic doses.
Schwarz K; de Giuli R; Schmidtke G; Kostka S; van den Broek M; Kim KB; Crews CM; Kraft R; Groettrup M
J Immunol; 2000 Jun; 164(12):6147-57. PubMed ID: 10843664
[TBL] [Abstract][Full Text] [Related]
11. Lactacystin, a specific inhibitor of the proteasome, induces apoptosis in human monoblast U937 cells.
Imajoh-Ohmi S; Kawaguchi T; Sugiyama S; Tanaka K; Omura S; Kikuchi H
Biochem Biophys Res Commun; 1995 Dec; 217(3):1070-7. PubMed ID: 8554559
[TBL] [Abstract][Full Text] [Related]
12. Proteasome inhibitors: valuable new tools for cell biologists.
Lee DH; Goldberg AL
Trends Cell Biol; 1998 Oct; 8(10):397-403. PubMed ID: 9789328
[TBL] [Abstract][Full Text] [Related]
13. The ubiquitin-proteasome system and cellular proliferation and regulation in osteoblastic cells.
Murray EJ; Bentley GV; Grisanti MS; Murray SS
Exp Cell Res; 1998 Aug; 242(2):460-9. PubMed ID: 9683533
[TBL] [Abstract][Full Text] [Related]
14. A beta-lactone related to lactacystin induces neurite outgrowth in a neuroblastoma cell line and inhibits cell cycle progression in an osteosarcoma cell line.
Fenteany G; Standaert RF; Reichard GA; Corey EJ; Schreiber SL
Proc Natl Acad Sci U S A; 1994 Apr; 91(8):3358-62. PubMed ID: 8159752
[TBL] [Abstract][Full Text] [Related]
15. Proteasome activity is critical for the cAMP-induced differentiation of neuroblastoma cells.
Nahreini P; Andreatta C; Prasad KN
Cell Mol Neurobiol; 2001 Oct; 21(5):509-21. PubMed ID: 11860188
[TBL] [Abstract][Full Text] [Related]
16. The proteasome is involved in angiogenesis.
Oikawa T; Sasaki T; Nakamura M; Shimamura M; Tanahashi N; Omura S; Tanaka K
Biochem Biophys Res Commun; 1998 May; 246(1):243-8. PubMed ID: 9600100
[TBL] [Abstract][Full Text] [Related]
17. 3-hydroxy-3-methylglutaryl coenzyme A reductase is sterol-dependently cleaved by cathepsin L-type cysteine protease in the isolated endoplasmic reticulum.
Moriyama T; Wada M; Urade R; Kito M; Katunuma N; Ogawa T; Simoni RD
Arch Biochem Biophys; 2001 Feb; 386(2):205-12. PubMed ID: 11368343
[TBL] [Abstract][Full Text] [Related]
18. Ubiquitin-proteasome system and increased sensitivity of B-CLL lymphocytes to apoptotic death activation.
Masdehors P; Merle-Béral H; Magdelénat H; Delic J
Leuk Lymphoma; 2000 Aug; 38(5-6):499-504. PubMed ID: 10953970
[TBL] [Abstract][Full Text] [Related]
19. Total synthesis and biological activity of lactacystin, omuralide and analogs.
Corey EJ; Li WD
Chem Pharm Bull (Tokyo); 1999 Jan; 47(1):1-10. PubMed ID: 9987821
[TBL] [Abstract][Full Text] [Related]
20. Lactacystin, proteasome function, and cell fate.
Fenteany G; Schreiber SL
J Biol Chem; 1998 Apr; 273(15):8545-8. PubMed ID: 9535824
[No Abstract] [Full Text] [Related]
[Next] [New Search]
